Not sure people are getting this so thought I would reiterate: B is the first of a completely new class of therapeutics. The majors want to see reproducibility and verification in double A. All the opinions floating around, in my opinion, are hogwash meant to cause volatility so traders can make pennies. My strategy: ignore the pumpers AND the naysayers. I think iB has a great chance of success, but that is my opinion. Anyone else who says they “know” is selling something